Vimarsana
Biggest News Aggregation in the World

Page 24 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Is MEI Pharma (MEIP) Attractively Priced? - Vimarsana News

Is MEI Pharma (MEIP) Attractively Priced?

GreenWood Investors LLC, an investment management firm, released its annual 2023 investor letter. A copy of the same can be downloaded here. 2023 was excellent for the fund’s investors, thanks to the collaborative and constructive engagements, which added immense value to the performance. Despite that, the firm is still seeking more challenges to continue to drive […]

Source: yahoo.com
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform - Vimarsana News

Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform

MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has ente...

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. ... - Vimarsana News

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. ...

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. ...

Bridgebio seeks Japan approval of acoramidis for rare heart disease - Vimarsana News

Bridgebio seeks Japan approval of acoramidis for rare heart disease

Armed with strong phase III safety data in Japanese patients, Palo Alto, Calif.-based Bridgebio Pharma Inc. is planning to file for Japan approval of its investigational drug acoramidis for a rare heart disorder.

FSD Pharma Inc. (NASDAQ:HUGE) Sees Significant Drop in Short Interest - Vimarsana News

FSD Pharma Inc. (NASDAQ:HUGE) Sees Significant Drop in Short Interest

FSD Pharma Inc. (NASDAQ:HUGE – Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 294,200 shares, a decrease of 7.3% from the December 31st total of 317,400 shares. Approximately 1.8% of the company’s shares are sold short. Based on an average daily volume […]